BetterMe Rx

Overview

BetterMe Rx is a cash-pay telehealth program selling compounded GLP-1s in four formats: injectable semaglutide from $155, injectable tirzepatide from $225, oral tablet semaglutide from $195, and oral tablet tirzepatide from $225. The needle-free daily tirzepatide tablet, priced at parity with the injection, is uncommon in the cash-pay market. A free evaluation, U.S.-licensed provider review, and discreet U.S. shipping round out the model. BetterMe Rx offers compounded semaglutide and tirzepatide in injectable and oral formats through licensed U.S. providers, with longer plans receiving lower monthly-equivalent pricing. Compounded GLP-1 treatment from $145/month on a 12-month plan. Semaglutide injection $205 monthly or as low as $145/month on 12-month plan. Tirzepatide injection $275 monthly or as low as $215/month. Oral semaglutide $250 monthly or as low as $185/month. Oral tirzepatide $265 monthly or as low as $215/month. Longer 3-, 6-, or 12-month supplies are billed according to the selected plan. Medication, provider review, pharmacy compounding, supplies and free 1–2 day shipping included. No membership fee, insurance or hidden fees. Cancel anytime. Compounded medications are not FDA-approved. Treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.